alpha-En Competitors

RCM Technologies (NASDAQ:RCMT) and alpha-En (NASDAQ:ALPE) are both small-cap business services companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, analyst recommendations and risk.

Profitability

This table compares RCM Technologies and alpha-En's net margins, return on equity and return on assets.

Earnings & Valuation

This table compares RCM Technologies and alpha-En's top-line revenue, earnings per share and valuation.

RCM Technologies has higher revenue and earnings than alpha-En.

Insider & Institutional Ownership

23.1% of RCM Technologies shares are owned by institutional investors. 23.5% of RCM Technologies shares are owned by company insiders. Comparatively, 57.7% of alpha-En shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Risk & Volatility

RCM Technologies has a beta of 1.87, meaning that its share price is 87% more volatile than the S&P 500. Comparatively, alpha-En has a beta of 0.78, meaning that its share price is 22% less volatile than the S&P 500.

Analyst Ratings

This is a summary of current recommendations and price targets for RCM Technologies and alpha-En, as provided by MarketBeat.com.

RCM Technologies presently has a consensus price target of $4.00, suggesting a potential upside of 11.42%. Given RCM Technologies' higher probable upside, research analysts clearly believe RCM Technologies is more favorable than alpha-En.

Summary

RCM Technologies beats alpha-En on 7 of the 9 factors compared between the two stocks.

Mmtec (NASDAQ:MTC) and alpha-En (NASDAQ:ALPE) are both small-cap business services companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, analyst recommendations and risk.

Insider & Institutional Ownership

0.7% of Mmtec shares are owned by institutional investors. 57.7% of alpha-En shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Analyst Ratings

This is a summary of current recommendations and price targets for Mmtec and alpha-En, as provided by MarketBeat.com.

Profitability

This table compares Mmtec and alpha-En's net margins, return on equity and return on assets.

Earnings & Valuation

This table compares Mmtec and alpha-En's top-line revenue, earnings per share and valuation.

Mmtec has higher revenue and earnings than alpha-En.

Risk & Volatility

Mmtec has a beta of 4.36, meaning that its share price is 336% more volatile than the S&P 500. Comparatively, alpha-En has a beta of 0.78, meaning that its share price is 22% less volatile than the S&P 500.

Summary

Mmtec beats alpha-En on 4 of the 5 factors compared between the two stocks.

alpha-En (NASDAQ:ALPE) and BioHiTech Global (NASDAQ:BHTG) are both small-cap business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, earnings, risk, dividends and analyst recommendations.

Insider and Institutional Ownership

1.8% of BioHiTech Global shares are owned by institutional investors. 57.7% of alpha-En shares are owned by insiders. Comparatively, 36.9% of BioHiTech Global shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Analyst Recommendations

This is a summary of current ratings and price targets for alpha-En and BioHiTech Global, as provided by MarketBeat.

BioHiTech Global has a consensus price target of $4.00, suggesting a potential upside of 194.12%. Given BioHiTech Global's higher probable upside, analysts plainly believe BioHiTech Global is more favorable than alpha-En.

Profitability

This table compares alpha-En and BioHiTech Global's net margins, return on equity and return on assets.

Earnings and Valuation

This table compares alpha-En and BioHiTech Global's gross revenue, earnings per share and valuation.

alpha-En has higher earnings, but lower revenue than BioHiTech Global.

Risk & Volatility

alpha-En has a beta of 0.78, meaning that its share price is 22% less volatile than the S&P 500. Comparatively, BioHiTech Global has a beta of 1.44, meaning that its share price is 44% more volatile than the S&P 500.

alpha-En (NASDAQ:ALPE) and Harte Hanks (NASDAQ:HRTH) are both small-cap business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, earnings, risk, dividends and analyst recommendations.

Insider and Institutional Ownership

3.3% of Harte Hanks shares are owned by institutional investors. 57.7% of alpha-En shares are owned by insiders. Comparatively, 8.1% of Harte Hanks shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Analyst Recommendations

This is a summary of current ratings and price targets for alpha-En and Harte Hanks, as provided by MarketBeat.

Harte Hanks has a consensus price target of $17.00, suggesting a potential upside of 209.09%. Given Harte Hanks' higher probable upside, analysts plainly believe Harte Hanks is more favorable than alpha-En.

Profitability

This table compares alpha-En and Harte Hanks' net margins, return on equity and return on assets.

Earnings and Valuation

This table compares alpha-En and Harte Hanks' gross revenue, earnings per share and valuation.

alpha-En has higher earnings, but lower revenue than Harte Hanks.

Summary

Harte Hanks beats alpha-En on 5 of the 9 factors compared between the two stocks.

alpha-En (NASDAQ:ALPE) and SPAR Group (NASDAQ:SGRP) are both small-cap business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, earnings, risk, dividends and analyst recommendations.

Insider and Institutional Ownership

6.9% of SPAR Group shares are owned by institutional investors. 57.7% of alpha-En shares are owned by insiders. Comparatively, 61.1% of SPAR Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Analyst Recommendations

This is a summary of current ratings and price targets for alpha-En and SPAR Group, as provided by MarketBeat.

Profitability

This table compares alpha-En and SPAR Group's net margins, return on equity and return on assets.

Earnings and Valuation

This table compares alpha-En and SPAR Group's gross revenue, earnings per share and valuation.

SPAR Group has higher revenue and earnings than alpha-En.

Risk & Volatility

alpha-En has a beta of 0.78, meaning that its share price is 22% less volatile than the S&P 500. Comparatively, SPAR Group has a beta of 1.27, meaning that its share price is 27% more volatile than the S&P 500.

Summary

SPAR Group beats alpha-En on 8 of the 8 factors compared between the two stocks.

alpha-En (NASDAQ:ALPE) and Sigma Labs (NASDAQ:SGLB) are both small-cap business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, earnings, risk, dividends and analyst recommendations.

Earnings and Valuation

This table compares alpha-En and Sigma Labs' gross revenue, earnings per share and valuation.

alpha-En has higher earnings, but lower revenue than Sigma Labs.

Analyst Recommendations

This is a summary of current ratings and price targets for alpha-En and Sigma Labs, as provided by MarketBeat.

Sigma Labs has a consensus price target of $5.00, suggesting a potential upside of 48.81%. Given Sigma Labs' higher probable upside, analysts plainly believe Sigma Labs is more favorable than alpha-En.

Insider and Institutional Ownership

0.9% of Sigma Labs shares are owned by institutional investors. 57.7% of alpha-En shares are owned by insiders. Comparatively, 4.6% of Sigma Labs shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares alpha-En and Sigma Labs' net margins, return on equity and return on assets.

Risk & Volatility

alpha-En has a beta of 0.78, meaning that its share price is 22% less volatile than the S&P 500. Comparatively, Sigma Labs has a beta of 1.45, meaning that its share price is 45% more volatile than the S&P 500.